XML 41 R30.htm IDEA: XBRL DOCUMENT v3.8.0.1
Investment in NEC TOKIN (Tables)
 9 Months Ended
Dec. 31, 2017
Equity Method Investments and Joint Ventures [Abstract]  
Reconciliation between NEC TOKIN's net loss and KEMET's equity investment loss
Summarized financial information for TOKIN follows (amounts in thousands):
 
Quarter Ended December 31, 2016
 
19 Day Period Ended April 19, 2017
 
Nine-Month Period Ended December 31, 2016
Sales
$
127,845

 
$
23,649

 
$
374,944

Gross profit
28,886

 
6,647

 
82,487

Net income (loss) (1)
1,082

 
247,786

 
5,444

_________________
(1) The significant change between the periods was due to the gain from the Sale of EMD that occurred on April 14, 2017; see the discussion in Note 2, “Acquisitions” for more information.
A reconciliation between TOKIN’s net income (loss) and KEC’s equity investment income (loss) follows (amounts in thousands):
 
Quarter Ended December 31, 2016
 
19 Day Period Ended April 19, 2017
 
Nine-Month Period Ended December 31, 2016
TOKIN net income (loss)
$
1,082

 
$
247,786

 
$
5,444

KEC’s economic interest %
34
%
 
34
%
 
34
%
Equity income (loss) from TOKIN before adjustments
368

 
84,247

 
1,851

 


 


 
 
Adjustments:


 


 
 
Amortization and depreciation
(562
)
 
(113
)
 
(1,686
)
Removal of EMD memo accounts
—

 
(8,981
)
 
—

Inventory profit elimination
61

 
24

 
106

Equity income (loss) from TOKIN
$
(133
)
 
$
75,177

 
$
271

Acquired equity method investment income (loss)
$
—

 
$
240

 
$
—

Equity income (loss) from equity method investments
$
(133
)
 
$
75,417

 
$
271
Schedule of Related Party Transactions
Summarized transactions between KEC and TOKIN are as follows (amounts in thousands):
 
Quarter Ended December 31, 2016
 
19 Day Period Ended April 19, 2017
 
Nine-Month Period Ended December 31, 2016
KEC’s sales to TOKIN
$
4,814

 
$
727

 
$
13,096

TOKIN’s sales to KEMET
2,350

 
356

 
6,112